Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GreenLight Biosciences Holdings, PBC - Common Stock (NQ: GRNA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about GreenLight Biosciences Holdings, PBC - Common Stock

GreenLight Announces Completion of Merger with Fall Line Endurance Fund
From GreenLight Biosciences
Via GlobeNewswire
GREENLIGHT BIOSCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of GreenLight Biosciences Holdings, PBC - GRNA
From Kahn Swick & Foti, LLC
Via Business Wire
GRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of GreenLight Biosciences Holdings, PBC Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
Completion of Previously Announced Merger and Going Private Transaction Expected July 20, 2023 
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences Releases Inaugural Sustainability Report
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D Day
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D Day
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences to Host R&D Day Series on Plant and Human Health Development Strategy
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences and Epivax Therapeutics Sign Exclusive Collaboration Agreement to Develop Personalized Cancer Vaccines
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences Announces Third Quarter 2022 Financial Results and Highlights Recent Company Progress
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences to Participate in Upcoming Investor Conferences in November
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences announces realignment to focus on near-term value drivers
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences and Queensland University of Technology partner to tackle destructive fall armyworm using RNA
From GreenLight Biosciences
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.